pomalidomide has been researched along with 2-(2,6-dioxopiperidin-3-yl)phthalimidine in 2 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (2-(2,6-dioxopiperidin-3-yl)phthalimidine) | Trials (2-(2,6-dioxopiperidin-3-yl)phthalimidine) | Recent Studies (post-2010) (2-(2,6-dioxopiperidin-3-yl)phthalimidine) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 21 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eger, K; Figg, WD; Gütschow, M; Hauschildt, S; Hecker, TK; Lepper, ER; Luzzio, FA; Ng, SS; Weiss, M | 1 |
| Che, J; Jones, LH; Kong, NR; Liu, H | 1 |
2 other study(ies) available for pomalidomide and 2-(2,6-dioxopiperidin-3-yl)phthalimidine
| Article | Year |
|---|---|
Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors.
Topics: Angiogenesis Inhibitors; Animals; Aorta, Thoracic; In Vitro Techniques; Male; Microcirculation; Models, Molecular; Molecular Conformation; Muscle, Smooth, Vascular; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Thalidomide | 2004 |
Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition.
Topics: | 2021 |